IMA
ImageneBio, Inc.
$6.02
-0.09 (-1.47%)
At close · Jul 14
Market Cap
$67.90M
Shares
11,279,130
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.02
Open$6.23
Day$5.90–6.23
52W$3.94–18.00
Avg vol 30d13K
Short int404K · 3.6% float · 31.5d
Short vol48%
Last earningsMay 15, 2026
DataMar 2021–Jul 2026
Filing10-Q · May 7
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.5 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
+5%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
15%
near low
Momentum
relative strength
1-month return
+7%
trailing
6-month return
−4%
trailing
YTD return
−13%
this year
Relative strength
−15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-5% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.59% of float · ▲ +2.1% MoM · 31.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
39 holders — 13F breadth
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
−77%
Y/Y
EPS growth
+56%
Y/Y
Free cash flow
$-48.3M
Balance sheet
$94.5M
net cash
Quant / Vol
risk profile
Volatility
74%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
+5%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
15%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-5% holders QoQ · +7 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.59% of float · ▲ +2.1% MoM · 31.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
39 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $4
Now $6 · 15%
52-wk high $18
vs 200-day avg -8%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMA
this stock
ImageneBio, Inc.
|
$67.90M | -12.8% | -77.1% | — | 3.6% |
|
ONC
BeOne Medicines Ltd.
|
$439.30B | +0.0% | +22179.2% | 894.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.89B | +5.9% | +46.2% | 28.5 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.52B | -14.0% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$53.77B | +2.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMA | -0.8% | +7.1% | -4.4% | +2.0% | -12.8% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | -1.4% | +5.8% | -15.4% | +1.4% | -23.0% |